Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record is now available, with details on the study design, eligibility criteria, treatments, outcomes, locations, and completion status.SummaryDifference76%

- Check18 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0; the 403 error page otherwise remains unchanged.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial page continues to display a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error with the standard 403 layout, replacing the study content. This indicates restricted access to the NCT03504488 record.SummaryDifference18%

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.